Skip to main content
News and Events banner photo

News & Events
Stay Informed with Industry Insights and Follow Our Progress

Scientist in background holding filled vial in foreground


Company News

Ractigen Therapeutics closes on $17 Million Series A to advance lead program into clinical phase, led by Hillhouse Venture Capital

February 10, 2021
Ractigen Therapeutics, a leading company in the saRNA drug space, announced that it has closed…
Company News

CB Insights lists Ractigen as one of the Top RNA biotech companies in China

May 19, 2020
Today, CB Insights China published, for the first time, a top list of RNA biotech…
Company News

Delegation from Nantong University Medical School visits Ractigen

July 11, 2018
Today, a 5-member delegation, led by the dean Professor Fei Sun, from Nantong University Medical…
Company News

Scientists from Ractigen and KRIBB publish new study on saRNA-guided activation of VHL gene in renal cell carcinoma

February 7, 2018
Today, an article entitled "Small activating RNA induced expression of VHL gene in renal cell…
Company News

The first book on RNAa published

July 12, 2017
Springer•Nature published a book edited by Ractigen’s founder, Dr. Long-Cheng LI and entitled “RNA Activation”.…
Company News

HS Talk published a lecture presented by Ractigen’s co-founder and CEO, Dr. Long-Cheng Li

April 30, 2017
Henry Stewart Talks which publishes animated audio visual presentations by world leading experts published a…